Variant report

Variant	esv1792444
Chromosome Location	chr7:25902015-25964180
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:0)
CpG islands
(count:0)
Chromatin interactive
region (count:102)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

No data

(count:102 , 50 per page) page: 1 2 3

No.	Distal block	Cell Line	Cell type
1	chr7:25935063..25935626-chr7:26100854..26101524,2	K562	blood:
2	chr7:25900279..25902478-chr7:26238832..26241424,3	K562	blood:
3	chr7:25932106..25933106-chr7:26707000..26708058,3	K562	blood:
4	chr7:25901348..25903877-chr7:25904726..25907059,2	K562	blood:
5	chr7:25953157..25955239-chr7:25965807..25967682,2	K562	blood:
6	chr7:25923786..25925594-chr7:25937071..25938601,2	MCF-7	breast:
7	chr7:25905009..25906710-chr7:26241408..26243816,2	K562	blood:
8	chr7:25952760..25954350-chr7:25989892..25992459,2	K562	blood:
9	chr7:25902131..25903827-chr7:25913868..25916119,2	K562	blood:
10	chr7:25956397..25958316-chr7:25961435..25964267,2	K562	blood:
11	chr7:25928700..25931118-chr7:25931774..25933928,2	K562	blood:
12	chr7:25909092..25911121-chr7:25913074..25914665,2	MCF-7	breast:
13	chr7:25911320..25913975-chr7:25915659..25917796,2	K562	blood:
14	chr7:25903944..25906495-chr7:25910268..25911868,2	K562	blood:
15	chr7:25901765..25903846-chr7:25928862..25931823,2	K562	blood:
16	chr7:25932861..25935776-chr7:26190366..26192075,2	MCF-7	breast:
17	chr7:25900544..25903827-chr7:25911333..25915801,5	K562	blood:
18	chr7:25901765..25903846-chr7:25928862..25931823,2	K562	blood:
19	chr7:25953417..25956574-chr7:25956816..25958986,3	K562	blood:
20	chr7:25900891..25903409-chr7:25932154..25934177,2	K562	blood:
21	chr7:25956397..25958316-chr7:25961435..25964267,2	K562	blood:
22	chr7:25930697..25932645-chr7:26238198..26240976,2	K562	blood:
23	chr7:25905073..25908133-chr7:25912915..25915642,3	K562	blood:
24	chr7:25957300..25959030-chr7:25962063..25963663,2	K562	blood:
25	chr7:25946705..25948507-chr7:25987208..25989031,2	K562	blood:
26	chr7:25902422..25904176-chr7:25907218..25908860,2	K562	blood:
27	chr7:25916222..25918065-chr7:25927760..25929290,2	K562	blood:
28	chr7:25925894..25927680-chr7:25929119..25930784,2	K562	blood:
29	chr7:25911320..25913975-chr7:25915659..25917796,2	K562	blood:
30	chr1:852317..853096-chr7:25906950..25907450,2	MCF-7	breast:
31	chr7:25929289..25931506-chr7:25934991..25936494,2	K562	blood:
32	chr7:25928700..25931118-chr7:25931774..25933928,2	K562	blood:
33	chr7:25929289..25930840-chr7:25934991..25937608,2	K562	blood:
34	chr7:25900544..25903827-chr7:25911333..25915801,5	K562	blood:
35	chr7:25893918..25894862-chr7:25932230..25933199,2	K562	blood:
36	chr7:25933522..25935904-chr7:26366723..26369511,2	K562	blood:
37	chr7:25919887..25922419-chr7:25922573..25924803,2	MCF-7	breast:
38	chr7:25905560..25907993-chr7:25932713..25935452,2	K562	blood:
39	chr7:25961990..25963849-chr7:25966309..25968265,2	MCF-7	breast:
40	chr7:25933071..25935143-chr7:26234757..26237027,2	K562	blood:
41	chr7:25939345..25941497-chr7:25950960..25952710,2	K562	blood:
42	chr7:25916222..25918065-chr7:25927760..25929290,2	K562	blood:
43	chr7:25900551..25904078-chr7:26238740..26241514,6	K562	blood:
44	chr7:25894376..25896556-chr7:25914929..25917518,2	K562	blood:
45	chr7:25902422..25904176-chr7:25907218..25908860,2	K562	blood:
46	chr7:25909092..25911121-chr7:25913074..25914665,2	MCF-7	breast:
47	chr7:25900989..25903469-chr7:26394737..26397654,2	K562	blood:
48	chr7:25934013..25935952-chr7:26413712..26416136,2	MCF-7	breast:
49	chr7:25934813..25935616-chr7:26101041..26101955,3	MCF-7	breast:
50	chr7:25901385..25904121-chr7:25989908..25991928,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NFE2L3-5	chr7:25932605-25933047	NONHSAT119607
2	lnc-HNRNPA2B1-11	chr7:25955640-25955975	expReg_chr7_2066_-
3	lnc-NFE2L3-5	chr7:25951299-25951446	NONHSAT119607

No data

Variant related genes	Relation type
ENSG00000225792	chromatin interactions
ENSG00000270933	chromatin interactions
ENSG00000122566	chromatin interactions
ENSG00000050344	chromatin interactions
ENSG00000122565	chromatin interactions
ENSG00000199085	chromatin interactions

Extended variants
information (count: 1811 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:1811 , 50 per page) page: 1 2 3 4 5 6 7 ... 37

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs71521738	chr7:25902020-25902021	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs575262394	chr7:25902031-25902032	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs187575813	chr7:25902032-25902033	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs12700668	chr7:25902038-25902039	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs576473702	chr7:25902066-25902067	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs375455262	chr7:25902068-25902069	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs376169362	chr7:25902077-25902078	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs371462061	chr7:25902098-25902099	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs552724370	chr7:25902128-25902129	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs77297912	chr7:25902138-25902139	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs528781208	chr7:25902172-25902173	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs112871324	chr7:25902184-25902185	Weak transcription Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs543864180	chr7:25902206-25902207	Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs62447906	chr7:25902217-25902218	Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs567221271	chr7:25902262-25902263	Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs550583619	chr7:25902266-25902267	Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs535856169	chr7:25902269-25902270	Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs576679627	chr7:25902328-25902329	Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs529841590	chr7:25902363-25902364	Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs367853867	chr7:25902376-25902377	Weak transcription Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs190363269	chr7:25902414-25902415	Weak transcription Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs553122712	chr7:25902420-25902421	Weak transcription Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs573000007	chr7:25902457-25902458	Weak transcription Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs535648810	chr7:25902458-25902459	Weak transcription Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs549288014	chr7:25902463-25902464	Weak transcription Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs555657498	chr7:25902471-25902472	Weak transcription Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs575622730	chr7:25902536-25902537	Weak transcription Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs181052089	chr7:25902635-25902636	Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs564096714	chr7:25902661-25902662	Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs577661749	chr7:25902701-25902702	Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs556253631	chr7:25902703-25902704	Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs540002498	chr7:25902716-25902717	Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs560198625	chr7:25902752-25902753	Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs185789204	chr7:25902769-25902770	Flanking Active TSS Active TSS Enhancers Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs139436321	chr7:25902839-25902840	Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs548390815	chr7:25902858-25902859	Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs562018503	chr7:25902861-25902862	Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs190111649	chr7:25902862-25902863	Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs550546612	chr7:25902904-25902905	Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs371260048	chr7:25902936-25902937	Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs13247087	chr7:25902945-25902946	Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs559928876	chr7:25902988-25902989	Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs77710972	chr7:25902995-25902996	Enhancers Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs559023178	chr7:25903018-25903019	Enhancers Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs533462072	chr7:25903049-25903050	Enhancers Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs569764119	chr7:25903064-25903065	Enhancers Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs528747559	chr7:25903093-25903094	Enhancers Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs535608806	chr7:25903129-25903130	Enhancers Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs552127649	chr7:25903148-25903149	Enhancers Bivalent Enhancer Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs182429387	chr7:25903224-25903225	Bivalent Enhancer Enhancers Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Autism	22495311	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Gastrointestinal stromal cancer	20877625	CNVD
Cancer	21637783	CNVD
Squamous cell cancer	20885788	CNVD
Breast cancer	16397240	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Glioblastoma multiforme	18628472	CNVD
Non-syndromic sensorineural hearing loss	22570644	CNVD
Cancer	21183584	CNVD
abnormal development	18461090	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Breast cancer	21785460	CNVD
Follicular lymphoma	20505157	CNVD
Williams-beuren syndrome	22470819	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Colorectal cancer	16774939	CNVD
Myelofibrosis	22110671	CNVD
Colorectal cancer	21645411	CNVD
Lung adenocarcinoma	17086460	CNVD
Colorectal cancer	19455253	CNVD
Lung cancer	17086460	CNVD
Breast cancer	18852474	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Acute myeloid leukemia	20962326	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:908 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:25900000-25902800	Active TSS	NHDF-Ad	bronchial
2	chr7:25900000-25903800	Active TSS	K562	blood
3	chr7:25900400-25902600	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
4	chr7:25900800-25902800	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
5	chr7:25901000-25902400	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
6	chr7:25901200-25902600	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr7:25901200-25902600	Bivalent Enhancer	Fetal Heart	heart
8	chr7:25901400-25902200	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
9	chr7:25901400-25902200	Active TSS	Colonic Mucosa	Colon
10	chr7:25901400-25902400	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
11	chr7:25901400-25902600	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
12	chr7:25901400-25902600	Active TSS	Skeletal Muscle Female	skeletal muscle
13	chr7:25901400-25902600	Bivalent/Poised TSS	GM12878-XiMat	blood
14	chr7:25901400-25902800	Bivalent Enhancer	Primary hematopoietic stem cells	blood
15	chr7:25901400-25903000	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
16	chr7:25901400-25903000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
17	chr7:25901600-25902200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
18	chr7:25901600-25902200	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
19	chr7:25901600-25902200	Bivalent Enhancer	Fetal Intestine Large	intestine
20	chr7:25901600-25902200	Flanking Bivalent TSS/Enh	Fetal Thymus	thymus
21	chr7:25901600-25902600	Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
22	chr7:25901600-25902600	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr7:25901600-25902600	Bivalent/Poised TSS	Brain Germinal Matrix	brain
24	chr7:25901600-25902600	Bivalent/Poised TSS	Fetal Brain Female	brain
25	chr7:25901600-25902600	Bivalent/Poised TSS	Rectal Smooth Muscle	rectum
26	chr7:25901600-25902600	Active TSS	A549	lung
27	chr7:25901600-25902800	Active TSS	Psoas Muscle	Psoas
28	chr7:25901600-25903000	Active TSS	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
29	chr7:25901600-25903000	Flanking Bivalent TSS/Enh	Monocytes-CD14+_RO01746	blood
30	chr7:25901800-25902200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
31	chr7:25901800-25902200	Bivalent Enhancer	Aorta	Aorta
32	chr7:25901800-25902400	Bivalent/Poised TSS	Primary T cells from cord blood	blood
33	chr7:25901800-25902400	Enhancers	Muscle Satellite Cultured Cells	--
34	chr7:25901800-25902400	Bivalent/Poised TSS	Hela-S3	cervix
35	chr7:25901800-25902400	Weak transcription	HMEC	breast
36	chr7:25901800-25902600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
37	chr7:25901800-25902600	Active TSS	Primary hematopoietic stem cells short term culture	blood
38	chr7:25901800-25902600	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
39	chr7:25901800-25902600	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
40	chr7:25901800-25902600	Bivalent Enhancer	Placenta	Placenta
41	chr7:25901800-25902800	Enhancers	HUES48 Cell Line	embryonic stem cell
42	chr7:25901800-25902800	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
43	chr7:25901800-25902800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
44	chr7:25901800-25902800	Flanking Bivalent TSS/Enh	Thymus	Thymus
45	chr7:25901800-25903000	Bivalent Enhancer	Primary B cells from peripheral blood	blood
46	chr7:25901800-25903000	Bivalent Enhancer	Fetal Stomach	stomach
47	chr7:25901800-25903000	Bivalent Enhancer	Stomach Mucosa	stomach
48	chr7:25902000-25902200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
49	chr7:25902000-25902200	Flanking Bivalent TSS/Enh	Primary T helper naive cells fromperipheralblood	blood
50	chr7:25902000-25902200	Bivalent Enhancer	Liver	Liver

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links